Net Income

Dubai-based robotics firm Micropolis AI is under scrutiny after a delayed annual report triggered a warning from the NYSE American exchange.

Newly independent, auto supplier Versigent will meet investors to prove its critical role in powering the EV and autonomous vehicle revolution.

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

Three ZenaTech AI drone platforms have entered the final cybersecurity phase for Blue UAS certification, a critical step to accessing the U.S. defense market.

With M&A veteran Jay Wright taking control, Worldwide NFT is ditching its namesake focus for an aggressive acquisition strategy in AI, robotics, and software.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

Natural Alternatives International posts a 23% sales surge but a wider net loss, betting on new financing and product innovation to fix profitability woes.

China's youth-focused video platform Bilibili reports a strong Q1, achieving net profit fueled by a 30% surge in ad revenue and record user engagement.

Hesai Group posts another profitable quarter and a major Mercedes-Benz deal, while unveiling a strategic pivot from hardware to a 'Physical AI' ecosystem.

Defying economic contraction, Bank Leumi reported the system's highest profits and a massive dividend, showcasing its resilience and strategic edge in a crisis.

With backing from Bain Capital and Armistice, the life sciences firm's latest offering aims to fund its push to automate pharmaceutical quality control.

Fresh off strong financial growth, Web3 fintech firm Antalpha is pivoting into AI, launching proprietary routing tech to bridge AI and digital assets.

Preclinical data for JUST-AAV shows enhanced brain delivery and reduced side effects, offering new hope for rare neurodegenerative diseases.

Record heat and soaring energy costs are straining wallets. New 'drop-in' heat pumps offer an affordable, high-efficiency upgrade without a major renovation.

With a new CSO known for pushing rare disease drugs to market, Arbor Biotechnologies signals a strategic shift from platform discovery to clinical execution.

Quince Therapeutics' drug LAM-001 posts strong Phase 2a data, showing meaningful functional gains for patients with severe pulmonary hypertension.

The annual Women of Impact Summit unites corporate leaders and changemakers to foster intergenerational dialogue and tangible community support.

Lighten and Datavant have teamed up to turn messy medical notes into regulatory-grade data, aiming to dramatically speed up life sciences research.

Facing global competition, new initiatives aim to demystify U.S. entry rules and showcase authentic American culture to boost post-pandemic tourism.

With 10 partner-owned drugs in clinics, MindWalk leverages its decades of wet-lab success to prove its new AI platform is more than just hype.